[
  {
    "ts": null,
    "headline": "Assessing Hologic (HOLX) Valuation After Its Recent 3-Month Share Price Climb",
    "summary": "Hologic (HOLX) has been quietly grinding higher, with shares up about 10% over the past 3 months, as investors warm to its steady revenue growth and improving profitability in women’s health diagnostics and devices. See our latest analysis for Hologic. Zooming out, Hologic’s roughly 10% 3 month share price return builds on a steadier uptrend this year, even as its 1 year total shareholder return remains modest. This suggests sentiment is improving but not euphoric at $74.93. If Hologic’s...",
    "url": "https://finnhub.io/api/news?id=2aa208430b3fbec21490e49d703d1306801928ded3f1d6b4d74dd1facfc3e56f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1766063300,
      "headline": "Assessing Hologic (HOLX) Valuation After Its Recent 3-Month Share Price Climb",
      "id": 137822124,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "Hologic (HOLX) has been quietly grinding higher, with shares up about 10% over the past 3 months, as investors warm to its steady revenue growth and improving profitability in women’s health diagnostics and devices. See our latest analysis for Hologic. Zooming out, Hologic’s roughly 10% 3 month share price return builds on a steadier uptrend this year, even as its 1 year total shareholder return remains modest. This suggests sentiment is improving but not euphoric at $74.93. If Hologic’s...",
      "url": "https://finnhub.io/api/news?id=2aa208430b3fbec21490e49d703d1306801928ded3f1d6b4d74dd1facfc3e56f"
    }
  }
]